Consultation and Experimental Design
Work with our specialists to create a personal study designed for your specific research objectives.
Because piRNAs have remarkable properties in regulating gene expression and maintaining genomic integrity, as well as their specificity and therapeutic possibilities, piRNAs make appealing candidates for novel therapeutic approaches for different diseases. Protheragen's service on piRNA target identification will enable scientists to investigate the therapeutic uses of piRNA, as well as assist in the development and application of related pharmaceutical products.
As a result of its regulatory function on gene expression and genome stability, piRNA has garnered significant interest as a potential target for disease therapeutics. piRNA can be regarded as a feasible target in disease therapy for the following reasons:
Gene Regulation
piRNAs mediate gene silencing and regulate transposable elements and gene expression. The dysregulation of piRNAs is associated with a wide spectrum of diseases that make these biomolecules promising therapeutic targets.
Disease Association
Recent findings have associated abnormal piRNA expression with certain diseases such as cancer, neurodegeneration, and metabolic disorders. Targeting piRNAs associated with specific diseases may provide a new avenue for therapy.
Epigenetic Modifications
The role of piRNAs in modifying epigenetics includes alterations to the structure of chromatin and the expression of genes. piRNAs, when targeted, have the potential to modify epigenetic alterations linked with certain diseases.
Precision Medicine
Due to their specificity in targeting particular genomic loci or transcripts, piRNAs have great potential for use in precision medicine. These unique properties make it suitable for development as a targeted therapy for affected individuals.
piRNAs have emerged as extraordinary therapeutic targets for many prominent diseases, such as cancer, neurological and reproductive disorders, viral infections, cardiovascular diseases, and even metabolic disorders. Researchers could target certain piRNAs to develop novel therapeutics that treat the underlying pathologies of these diseases.
Disease Category | Disease | piRNA Target | Function of Target | Therapeutic Potential |
Cancer | Breast Cancer | piR-823 | Promotes tumor growth by regulating cell proliferation. | Inhibits tumor growth and metastasis. |
Colorectal Cancer | piR-54265 | Suppresses tumor suppressor genes. | Restores tumor suppressor function and inhibits cancer progression. | |
Lung Cancer | piR-651 | Regulates cell cycle and apoptosis. | Induces apoptosis and inhibits tumor proliferation. | |
Gastric Cancer | piR-3676 | Low expression linked to cancer progression. | Restoring piR-3676 expression could suppress tumor growth. | |
Neurological Disorders | Alzheimer's Disease | piR-34269 | Regulates amyloid-beta production. | Reduces amyloid-beta plaques and slows disease progression. |
Parkinson's Disease | piR-2107 | Targets alpha-synuclein (SNCA) expression. | Prevents alpha-synuclein aggregation and protects neurons. | |
Reproductive Disorders | Male Infertility | piR-36743 | Essential for spermatogenesis and germ cell development. | Restores normal spermatogenesis and improves fertility. |
Viral Infections | HIV/AIDS | piR-36000 | Targets HIV-1 RNA for degradation. | Inhibits viral replication and reduces viral load. |
Hepatitis B Virus Infection | piR-29116 | Targets HBV RNA for silencing. | Suppresses HBV replication and reduces liver damage. | |
Cardiovascular Diseases | Hypertension | piR-12345 | Regulates angiotensin-converting enzyme (ACE) expression. | Lowers blood pressure and improves cardiovascular health. |
Metabolic Disorders | Type 2 Diabetes | piR-65432 | Regulates insulin receptor substrate 1 (IRS1) expression. | Enhances insulin sensitivity and improves glucose metabolism. |
Protheragen uses modern technology to provide efficient piRNA target identification services that allow researchers to investigate the therapeutic possibilities and molecular mechanisms of piRNAs. Our services are customized to identify and validate piRNAs with high specificity which help understand the role of piRNAs in regulatory processes, genome integrity, and disease progression. Regardless of cancer, neurodegenerative disorders, or infectious disorders, our unique offerings enhance your research by providing credible and useful information.
Consultation and Experimental Design
Work with our specialists to create a personal study designed for your specific research objectives.
Sample Preparation
Isolate RNA from your specimens, including but not limited to tissues, cells, and biofluids.
piRNA Profiling and Target Prediction
Profile piRNA expression and assess potential targets with high-throughput piRNA sequencing, followed by data mining to predict targets.
Target Validation
Through functional assays including, but not limited to, luciferase reporter assay, qPCR, Western blot, validate predicted targets.
Data Analysis and Reporting
Conduction of thorough data analysis that encompasses target-pathway mapping, functional annotation, and visualization. Provide a report that includes valuable information and actionable insights.
Our scientists can identify piRNA targets for the therapeutic research of various diseases, including but not limited to the following:
Category | Diseases | ||
Cancer |
|
|
|
Neurodegenerative Diseases |
|
|
|
Infectious Diseases |
|
|
|
Reproductive System Diseases |
|
|
|
Metabolic and Cardiovascular Diseases |
|
|
|
Protheragen's piRNA target identification services help you discover key piRNA targets for diseases, paving the way for innovative therapy development. Contact us today to discuss your project and learn how we can support your research goals.
Reference